Healthy living by age
The U.S. Food and Drug Administration (FDA) has requested changes to the warnings in hormone therapy labeling and has approved updated labeling for the first products. Learn what changed, who benefits most, and what to ask your health care provider.
What changed in 2025 and 2026?
In November 2025, the FDA requested the removal of risk statements about heart disease, breast cancer, and probable dementia from the boxed warning in hormone therapy labeling.
Turning Blood Pressure Awareness into Action
National Women's Blood Pressure Awareness Week (NWBPAW) 2026 focuses on the everyday choices, preventive care, and evidence-based actions that can support healthier blood pressure and better health across the lifespan.
The NWHW 2026 Toolkit is designed to help individuals and organizations raise awareness and promote conversations about important women's health concerns.
National Women’s Health Week 2026 reflects an important shift in how women’s health is understood, supported, and advanced. Increasingly, care is moving toward a more proactive, connected, and science-driven approach—one that prioritizes early action, incorporates new discoveries, and ensures those advances translate into meaningful improvements in everyday health. This evolving model recognizes that better outcomes are achieved not through isolated moments of care, but through continuous, informed engagement across the lifespan.
The four focus areas include:
National Women’s Health Week (NWHW) is a time to focus on the health needs of women and girls at every stage of life. Each year, the observance highlights key topics and encourages women to take steps to protect and improve their health.
